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The existing gender gap in public health affects the areas of medical research, employment, and 
accurate diagnosis and treatment of medical conditions for women.  Women face a large 
disadvantage in such areas, and this problem must be addressed through improved policies and 




 Gender bias contributes to the considerable gender gap found in higher-level medical 
community employment. 
 Gender bias hinders the accurate diagnosis and treatment of female patients. 
 Gender bias contributes to the lack of substantial medical research on women. 
 Safety concerns and social factors are the primary causes of gender bias against women. 
 Gender bias must be overcome in order to achieve progress in targeting gender-specific 
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Brief 
 
 The past two decades of American history have brought unprecedented recognition to the 
women and gender issues regarding public health.  The Reagan and subsequent Bush 
administrations marked a steady erosion of the affirmative action policies implemented in 
previous decades, and it was only with the general return to liberal domestic policies during the 
Clinton presidency that the opportunity arose for the nation to address the serious inadequacies 
existing in healthcare for women.  Gender gaps and biases present serious hurdles in terms of 
medical employment, research, accurate diagnosis and effective, preventive treatment for 
women.  In order to overcome such hurdles, serious attention by the government and medical 
community to the task of eliminating gender biases from public health policies is imperative.   
 The great discrepancy between the numbers of males and females employed in the upper 
echelons of the medical community has a detrimental effect on the quality of healthcare for 
women in general.  Gender bias against women greatly impedes the advancement of female 
medical students and physicians, leading to the significant gender gap that exists in the 
healthcare community.  In 2005, there were only eleven medical school deans in the United 
States, a clear minority considering the fact that there are 126 teaching institutions.  While the 
number of female physicians and medical school applicants has risen drastically over the past 
decade, women remain a significant minority in the traditionally male-dominated fields of 
education and management.  The primary reasons for the discrepancies arise from simple hiring 
practices:  more white men are hired for tenure-track positions, enjoy a higher tenure and 
promotion rate, receive significantly higher salaries, and are proportionally overrepresented in 
upper-levels of administration where decisions are made.  Women are considerably more 
vulnerable than men in terms of employment since most are not protected by tenure and suffer 
from the consequences of the social stereotype that many women do not necessarily need to 
work.   
 Research on women’s health issues is also greatly affected by gender bias.  Until the 
early 1990s, women possessing childbearing potential were ineligible to participate in early 
stages of clinical trials, which stemmed from fears that trials on women could potentially harm 
fetuses, or that women could become pregnant during the course of a trial.  As a result, very little 
was known about the effects of many drugs on women, posing serious implications since women 
experience worse and more adverse effects from medicine than men.  It was only in 1993 that 
Congressional legislation required the inclusion of women in trials funded by the National 
Institution of Health (NIH).  The Food and Drug Administration (FDA) soon after lifted a ban on 
trials on women with childbearing potential.  However, the private medical and pharmaceutical 
sectors still reveal a large gender gap resulting from research done primarily on white, middle-
aged men.  This gender gap significantly limits understanding of women’s health concerns and 
gender-specific needs. 
 Gender bias also affects the differential treatment of female patients.  Physicians and 
other health professionals are more likely to attribute women’s health complaints to emotional 
causes rather than physical ones, demonstrating the troublesome tendency of the medical 
community to be influenced by social, non-scientific factors.  An example of this can be seen in 
the fact that mental health professionals are much less likely to accurately predict a woman’s 
potential for future violent action since socially, women have a lower rate of violence than men 
and women’s involvement in violence is often less visible than that of men.  Another example is 
that while in general women receive more healthcare than men, major diagnostic and therapeutic 
interventions are much more frequently performed on men.  Women are more likely to receive 
dialysis treatments while more men receive kidney transplants.  Similarly, men are 6.5 times 
more likely to receive cardiac catheterizations while women’s cardiac symptoms are twice as 
likely to be diagnosed as resulting from psychiatric or non-cardiac causes. 
 An area of women’s health that suffers greatly from existing biases is that of preventive 
medicine, especially in regard to reproductive health.  Females of age 9-25 are the least likely to 
gain access to reproductive healthcare, and are limited most by inherent social structures and 
biases.  The current debate over universal administration of the HPV vaccine to young, 
adolescent girls highlights this problem most potently.  The HPV vaccine prevents infections that 
cause over 70% of all cervical cancers and is most effective when administered to girls between 
the ages of 10-14, prior to sexual exposure.  However, since HPV is sexually transmitted, many 
social conservative groups in the United States oppose widespread and mandatory administration 
of the vaccine on the grounds that it would supposedly promote sexual activity in teenage girls.  
A large population of young girls, therefore, is prevented from receiving a potentially life-saving 
vaccination because of existing social stigmas.   
 Gender bias must be fully eradicated in the medical community in order to fully serve the 
distinct healthcare needs of women.  While the government and medical community have taken 
great steps within the past two decades the address such needs, much progress is still needed.  In 
particular, a conscious and active recognition and battling of the social stereotypes and stigmas 
that negatively influence the care received by women is imperative for further progress.  The 
lack of substantial research, a significant gender gap in medical employment, and social 
influences that negatively affect the accurate diagnosis and treatment of women all pose 
significant challenges to the field of women’s health. 
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